AUROBINDO PHARMA LTD. - 524804 - Unit 2 Of Apitoria Pharma Pvt. Ltd., Received EIR From US FDA With VAI Classification

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer

1093.3000 7.30 (0.67%)

NSE Oct 03, 2025 15:31 PM

28.07% Fall from 52W High

Volume: 517.5K

Aurobindo Pharma Ltd.

28 Jan 2025

1093.30

0.67%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Unit 2 Of Apitoria Pharma Pvt. Ltd., Received EIR From …

BSE India

This is to inform you that Unit 2 of Apitoria Pharma Pvt.Ltd., received EIR from USFDA with VAI classification.

More from Aurobindo Pharma …

All earning calls

Investor presentations from Aurobindo Pharma …

All investor presentations